Accueil - HSeT - Sciences e-Training Foundation

EVERYTHING THAT TRAINERS NEED TO DEVELOP ONLINE INTERACTIVE COURSES IN HEALTH SCIENCES

WHAT IS HSET

HSeT is a non-profit organization that works with a network of leading experts from all over the world to develop online training programs in health and life sciences for teaching institutions.

HOW IT WORKS

Training programs developed by HSeT are delivered through institution-specific websites. They can be used to augment an existing curriculum or construct a new curriculum. They can be reviewed by learners in a self-directed way or in combination with traditional face-to-face teaching.

EDUCATIONAL CONCEPT

HSeT provides Customized On Line Training (COLT): training programs tailored to the needs of specific groups of learners as defined by the institutions themselves. COLT integrates novel pedagogical approaches and tools to map student’s individual progress at every step.

REPORT FROM THE PRESIDENT

NEW COURSES & MORE ABOUT HSeT EVENTS

ANNUAL REPORT 2022

2023 Flagship programs

On-line training for the International Association of Geriatrics and Gerontology (IAGG) of the Federation of Geriatric Education (FGE)(IAGG)

Advanced Studies in Translational Nephrology (University of Zürich)

CAFE-S is a program launched in partnership between HSeT and the Faculty of Sciences of the University of Geneva to help future students fill in their gap in mathematics (University of Geneva)

The Translational Nephrology CAS/DAS (15/30 ECTS) is
offered in collaboration by the Universities of Zurich and Bern.
The program includes 6 modules (3 modules/year) over a period of 2 years.
Each module starts and ends with a hybrid (face-to-face and online) half-day session, The end of each module overlaps the beginning of the next one.
www.weiterbildung.uzh.ch/whp/programme/kurs/translational-nephrology
www.nephrologie.unibe.ch/

Deshnee Achary, a student of the International Master of Vaccinology (IMVACC) class 2021, working at Pfizer vaccines in Johannesburg South Africa, received an award from the former President of South Africa Thabo Mbeki and The University of South Africa Principal and Vice-Chancellor (VC), Professor Puleng LenkaBula, who honored her for the work she has done in vaccines for the past 17 years.

The Board of directors, June 24, 2021
The Board has appointed a new member Jean Gruenberg, PhD, Emeritus Professor, University of Geneva to replace Dominique Sprumont from the University of Neuchâtel, who resigned. The Board expresses its gratitude for Dominique’s commitment and contribution over the past years.

The Board of directors, March 15, 2021
The Board has appointed two new members:
Armelle, Phalipon, PhD, Research Director at Institut Pasteur, Paris to replace Nicolas Fasel from the Faculty of Biology and Medicine, University of Lausanne, who decided to leave the Board.
François Verrey, MD, Emeritus Professor, Zurich University, to replace Jonathan Fuchs from the Public Health Institute of San Francisco.
The Board expresses its gratitude to N. Fasel and J. Fuchs for their commitment and contribution over the past years.

June 10 2021
Duduzile Ndwandwe, from South Africa, defended with success her IMVACC Master thesis entitled “Prevalence and determinants of missed opportunities for vaccination in South Africa: a multi-level analysis”. She has been awarded the diploma and 60 ECTS from the University of Lausanne, Switzerland.